Similar articles

• In postmenopausal women with osteoporosis, romosozumab followed by alendronate reduced fractures vs alendronate alone.

  Hirsch C. Hirsch C. Ann Intern Med. 2018 Jan 16;168(2):JC3. doi: 10.7326/ACPJC-2018-168-2-003. Ann Intern Med. 2018. PMID: 29335715 No abstract available.
• [Osteoporotic fracture in menopausal women: alendronate reduces the risk].

  Bize R, Lamy O, Peytremann-Bridevaux I. Bize R, et al. Rev Med Suisse. 2008 Dec 10;4(183):2703. Rev Med Suisse. 2008. PMID: 19157286 French. No abstract available.
• Atypical femoral fractures bilaterally in a patient receiving denosumab.

  Drampalos E, Skarpas G, Barbounakis N, Michos I. Drampalos E, et al. Acta Orthop. 2014 Feb;85(1):3-5. doi: 10.3109/17453674.2013.854668. Epub 2013 Oct 31. Acta Orthop. 2014. PMID: 24171686 Free PMC article. No abstract available.
• Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review.

  Fink HA, MacDonald R, Forte ML, Rosebush CE, Ensrud KE, Schousboe JT, Nelson VA, Ullman K, Butler M, Olson CM, Taylor BC, Brasure M, Wilt TJ. Fink HA, et al. Ann Intern Med. 2019 Jul 2;171(1):37-50. doi: 10.7326/M19-0533. Epub 2019 Apr 23. Ann Intern Med. 2019. PMID: 31009947
• Fractures related to bone fragility: prevention First-choice treatments.

  [No authors listed] [No authors listed] Prescrire Int. 2017 Apr;26(181):103-106. Prescrire Int. 2017. PMID: 30730663 Review. No abstract available.